MolPort is exhibiting at the 6th ECBS/LS-EuChemS meeting from 3rd until 5th April, 2019 in Madrid, Spain.Chemical biologists from all parts of Europe and overseas come together to present and discuss the latest achievements in cutting edge chemical sciences. This present joint meeting gathers researchers from organic & biological chemistry, proteins biotechnology, computational biology, protocells, machine learning, bacterial resistance, drug discovery, synthetic biology, biomedical materials and chemical glycobiology. Drop by and chat with our colleague…

Meet us at 6th Computationally Driven Drug Discovery Meeting on 28th and 29th of March in Rome, Italy.The convention aims to gather together researchers who make use of techniques such as computational chemistry, chem-informatics, QSAR, property prediction to direct their effort towards integrated drug discovery program.We would be happy to have conversation with you about compound sourcing, database web services, reformatting, reweighing and other.Please contact our team member Andrii Lozoniuk. Or write us to sales@molport.com

We are attending KNIME Spring Summit in Berlin, from 18th until 22nd March. There’ll be leading data scientists, highlighting how they use KNIME Software for solving data problems across industries. We use it internally and provide KNIME nodes to access MolPort compound availability data.For those who want more data we have available ready workflows to automatically download MolPort database using KNIME. Please contact our team member Andrii Lozoniuk to arrange conversation or meet him on…

We’re exhibiting at the SLAS 2019 European Sample Management Symposium, March 11-12, 2019 in Berlin, Germany. MolPort will be there with our Screening compound sourcing platform and services together with colleagues from academia and industry who will present best practices, case studies, and the latest on how research organizations are evolving by partnering with biological and clinical groups to support – and reinvent – modern drug discovery processes.